Aardvark Therapeutics, Inc.
Aardvark Therapeutics develops small-molecule therapeutics targeting hunger signaling for Prader-Willi Syndrome and metabolic diseases.
SCHEDULE 13G/ANov 16Latest SEC filing
Nov 13Latest story
November 2026
October 2026
September 2026
August 2026